8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_______________

FORM 8-K

__________________

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(D)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported) January 30, 2018

__________________

DANAHER CORPORATION
	(Exact Name of Registrant as Specified in Its Charter)

__________________

Delaware

(State or Other Jurisdiction of Incorporation)

001-08089	59-1995548
(Commission File Number)	(IRS Employer Identification No.)
2200 Pennsylvania Avenue, NW, Suite 800W, Washington, D.C.	20037-1701
(Address of Principal Executive Offices)	(Zip Code)

202-828-0850

(Registrant’s Telephone Number, Including Area Code)

Not applicable

(Former Name or Former Address, if Changed Since Last Report)

__________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company o

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS

On January 29, 2018, Daniel L. Comas, Executive Vice President and Chief Financial Officer of Danaher Corporation (the “Company” or “Danaher”), notified the Company that he plans to relinquish his role as Chief Financial Officer as of December 31, 2018, after which he will continue as an Executive Vice President of the Company and as a member of the Office of the Chief Executive as he begins a gradual transition to retirement. Effective January 1, 2019, Mr. Comas will be succeeded as Chief Financial Officer by Matthew R. McGrew, 45, currently a Danaher Group CFO with responsibility for the Diagnostics and Dental platforms. Since joining Danaher in 2004, Mr. McGrew has served in a series of progressively more responsible positions in the Company’s finance and investor relations organizations, including as Vice President-Investor Relations from 2009 to May 2014. He assumed the role of Group CFO in May 2012.

The Company issued a press release on January 30, 2018 announcing the anticipated CFO transition. A copy of the press release is attached as Exhibit 99.1 to this report and incorporated by reference herein.

ITEM 9.01	FINANCIAL STATEMENTS AND EXHIBITS
(c)	Exhibits:
Exhibit No.		Description
99.1		Press release — "Danaher Announces Transition Plan for Chief Financial Officer"

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

			DANAHER CORPORATION
Date:	January 30, 2018	By:	/s/ James F. O’Reilly
			James F. O’Reilly
			Vice President, Associate General Counsel and Secretary

EX-99.1

Exhibit 99.1

DANAHER ANNOUNCES TRANSITION PLAN FOR CHIEF FINANCIAL OFFICER

Washington, D.C., January 30, 2018 — Danaher Corporation (NYSE: DHR) today announced that, effective January 1, 2019, Matthew R. McGrew, Group CFO of the Company’s Diagnostics and Dental platforms, will succeed Daniel L. Comas as Chief Financial Officer. Mr. Comas will continue as an Executive Vice President of the Company, and a member of the Office of the Chief Executive, effective January 1, 2019 as he begins a gradual transition to retirement.

Thomas P. Joyce, Jr., President and Chief Executive Officer, stated, “I have had the opportunity to work with Matt over the past fourteen years. During his tenure at Danaher, Matt has consistently demonstrated superior leadership and has played an integral role in the corporation’s growth, both organically and inorganically. Matt is uniquely qualified to take on this important role. He brings together extensive Danaher experience in internal audit, M&A, investor relations, and as Group CFO, with operational experience across four of our five platforms.”

Joyce continued, “It has been a privilege for me to work with Dan Comas for over 25 years. All of us at Danaher value his outstanding financial stewardship, thoughtful guidance and long-time friendship. Danaher would not be where it is today without his leadership, strategic vision, and humility. We are very pleased that Dan will continue to work with us for some time to ensure a seamless CFO transition, and provide the strategic counsel we value so highly.”

Mr. Comas, 54 years old, has served as Company CFO since April 2005. He joined Danaher in 1991 in the Corporate Development organization. Since taking over as CFO in 2005, Danaher’s revenues have more than doubled to $18 billion and its market capitalization has increased four-fold to approximately $70 billion, with shareholder returns more than double that of the S&P500 Index.

Mr. McGrew, 45 years old, has served as a Danaher Group CFO since 2012, during which he has had responsibility at various times for the Company’s Life Sciences (including Pall), Product Identification, Diagnostics, and Dental platforms. He served as Vice President, Investor Relations from 2009 to 2014 and started at Danaher in 2004 as Director, M&A Finance. Prior to joining Danaher, Mr. McGrew was a Director in the Transaction Services Group at KPMG. He holds a Bachelor of Science degree in Accounting from DePaul University.

ABOUT DANAHER

Danaher is a global science and technology innovator committed to helping its customers solve complex challenges and improving quality of life around the world. Its family of world class brands has leadership positions in some of the most demanding and attractive industries, including health care, environmental and industrial. With more than 20 operating companies, Danaher's globally diverse team of approximately 67,000 associates is united by a common culture and operating system, the Danaher Business System. For more information, please visit www.danaher.com.

CONTACT

Matthew E. Gugino

Vice President, Investor Relations

Danaher Corporation

2200 Pennsylvania Avenue, N.W., Suite 800W

Washington, D.C. 20037

Telephone: (202) 828-0850

Fax: (202) 828-0860